SCHEMBL6219681

SCHEMBL6219681

CSc1nc(-c2ccccc2)c2c(N)c(C(=O)OCC3C4CC5CC(C4)CC3C5)sc2n1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LHCGR P22888 8/20 0.51
▸ TSHR P16473 2/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ KDM4E B2RXH2 6/20 0.46
▸ MAPT P10636 6/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ TDP1 Q9NUW8 2/20 0.41
▸ FSHR P23945 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ LIMK1 P53667 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ DUSP3 P51452 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6216192 0.83 ALDH1A1 (0.62) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6216808 0.82 LHCGR (0.64) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6217061 0.81 LHCGR (0.57) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6216728 0.80 LHCGR (0.65) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6215139 0.79 LHCGR (0.59) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6217253 0.78 LHCGR (0.51) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6217511 0.78 LHCGR (0.65) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6217985 0.78 LHCGR (0.53) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6216780 0.78 LHCGR (0.53) LHCGRTSHRALDH1A1KDM4EMAPT
SCHEMBL6216455 0.78 LHCGR (0.59) LHCGRTSHRALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1171443-B1 BICYCLIC HETEROAROMATIC COMPOUNDS USEFUL AS LH AGONISTS AKZO NOBEL NV (NL) 2005-07-13 — — EP disclosed
US-6841553-B2 Bicyclic heteroaromatic compounds useful as LH agonists AKZO NOBEL N.V. (NL) 2005-01-11 — — US disclosed
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists MERCK SHARP & DOHME B.V. (NL) 2003-11-13 — — US disclosed
US-6569863-B1 Luteinizing hormone (LH) agonists for controlling fertility AKZO NOBEL NV (NL) 2003-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists LHCGR, GNRHR, FSHR LHCGR 1/4885TSHR 176/4885ALDH1A1 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback